Status:
UNKNOWN
Wearable Blood Pressure Devices to Identify Masked Uncontrolled Hypertension.
Lead Sponsor:
National Taiwan University Hospital Hsin-Chu Branch
Conditions:
Hypertension,Essential
Hypertension, Masked
Eligibility:
All Genders
30-85 years
Brief Summary
Uncontrolled out-of-office blood pressure (BP), measured by either home BP monitoring (HBPM) or ambulatory BP monitoring, has been shown to predict higher cardiovascular risk. However, HBPM could not ...
Detailed Description
Recent hypertension guidelines stressed the importance of out-of-office BP monitoring. Ambulatory BP (ABPM) and home BP monitoring (HBPM) both predict future cardiovascular events better than office B...
Eligibility Criteria
Inclusion
- Willing to sign informed consent form
- Currently taking anti-hypertensive therapy for more than 3 months
- Drugs are unchanged during the study period
- Office BP below 140/90 mmHg at least one visit
Exclusion
- Diagnosed with terminal illness
- End-stage renal disease requiring lifelong dialysis treatment
- Patients with impaired performance status (ECOG \>= 2)
- Women undergoing or expecting pregnancy during the study period
- Resistant hypertension (taking more than 4 kinds of anti-hypertensive drugs)
- Known atrial or ventricular arrhythmia
- Wrist circumference out-of range between 13.5 to 21.5 cm
Key Trial Info
Start Date :
November 26 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04863508
Start Date
November 26 2020
End Date
October 1 2021
Last Update
April 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital Hsin-chu Branch
Hsinchu, Taiwan, 300